Daiichi Sankyo News and Activities

Presence

Daiichi Sankyo develops, makes, and sells prescription medicines and healthcare products. Its main offerings include cancer treatments, cardiovascular medicines, and vaccines for hospitals, clinics, and patients worldwide.

Daiichi Sankyo products and services overview:

  • Cancer medicines
  • Cardiovascular drugs
  • Vaccines
  • Prescription medicines
  • Biologic therapies
  • Healthcare products

Revenue: ~$13 billion

Employees: 19,000

Headquarters: Tokyo, Japan


Daiichi Sankyo is one of the...

Daiichi Sankyo is a company listed under the stock ticker 4568 (JP).

Daiichi Sankyo has a direct presence in 10 countries.

Daiichi Sankyo has 11 subsidiaries including American Regent, ASCA and Daiichi Sankyo Benelux.

They are in:

Executives

View the org chart displaying its 116 main executives

Most searched biographies at Daiichi Sankyo
Popular executive movements at Daiichi Sankyo
  • John Tsai has joined the company as Global Head of Research and Development  (posted on February 20 2026).
  • Ken Takeshita, Head of Research & Development Unit, will leave the company on Apr. 1, 2026  (posted on February 20 2026).
  • Veronika Rozehnal has joined the company as Head of Translational Research, Center Europe  (posted on January 22 2026).

Create your alert
to follow the executive moves at Daiichi Sankyo.

News

Press releases by Daiichi Sankyo
Social media about Daiichi Sankyo

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.